Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9788883 | 0.77 | POLB (0.37) | GAAALDH1A1 | |
| SCHEMBL9261804 | 0.70 | IMPDH2 (0.45) | — | |
| SCHEMBL7751350 | 0.68 | GABRA1 (0.46) | GAAALDH1A1 | |
| SCHEMBL28107458 | 0.68 | CYP3A4 (0.34) | ALDH1A1 | |
| SCHEMBL13978658 | 0.67 | GABRA1 (0.48) | GAAALDH1A1 | |
| SCHEMBL29829217 | 0.67 | GABRA1 (0.48) | GAAALDH1A1 | |
| SCHEMBL14816113 | 0.67 | NPSR1 (0.34) | GAAALDH1A1 | |
| SCHEMBL670463 | 0.67 | PTGDR (0.33) | ALDH1A1 | |
| SCHEMBL10480235 | 0.67 | GABRA1 (0.48) | GAAALDH1A1 | |
| SCHEMBL20831073 | 0.67 | ALDH1A1 (0.42) | GAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE46856-E1 | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-05-22 | — | — | US | disclosed |